Lipid-lowering drugs.
D002386:Cataract / Q000139:chemically induced; D008076:Cholesterol, HDL / Q000097:blood; D003327:Coronary Disease / Q000517:prevention & control; D015248:Gemfibrozil; D006801:Humans; D000960:Hypolipidemic Agents / Q000009:adverse effects / Q000627:therapeutic use; D010421:Pentanoic Acids / Q000009:adverse effects / Q000627:therapeutic use
D008076:Cholesterol, HDL; D000960:Hypolipidemic Agents; D010421:Pentanoic Acids; D015248:Gemfibrozil